Company | Name | Exchange | Sector | Industry | Analyst Recommendation | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Innova Captab | BSE | Healthcare | Pharmaceuticals | 1.5 | ₹4.78KCr | 39.7x | 1.86 | ₹848.35 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.5% Upside | Upgrade to Pro+ | |
Entero Healthcare Solutions | BSE | Healthcare | Healthcare Equipment & Supplies | 1.5 | ₹4.96KCr | 61.7x | 0.52 | ₹1,119.05 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.7% Upside | Upgrade to Pro+ | |
Entero Healthcare Solutions | NSE | Healthcare | Healthcare Equipment & Supplies | 1.5 | ₹4.96KCr | 61.7x | 0.52 | ₹1,118.60 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.6% Upside | Upgrade to Pro+ | |
Innova Captab | NSE | Healthcare | Pharmaceuticals | 1.5 | ₹4.78KCr | 39.7x | 1.86 | ₹847.60 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.5% Upside | Upgrade to Pro+ | |
Apollo Hospitals | BSE | Healthcare | Healthcare Providers & Services | 1.57 | ₹1.01LCr | 70.2x | 1.15 | ₹7,060.80 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Apollo Hospitals | NSE | Healthcare | Healthcare Providers & Services | 1.57 | ₹1.01LCr | 70.2x | 1.14 | ₹7,063.50 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Fortis Healthcare | BSE | Healthcare | Healthcare Providers & Services | 1.6 | ₹57.26KCr | 73x | 2.48 | ₹754.85 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4% Upside | Upgrade to Pro+ | |
Fortis Healthcare | NSE | Healthcare | Healthcare Providers & Services | 1.6 | ₹57.26KCr | 73x | 2.48 | ₹755.25 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | |
Emcure Pharmaceuticals | BSE | Healthcare | Pharmaceuticals | 1.67 | ₹25.12KCr | 36.9x | 1.14 | ₹1,312.35 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.7% Upside | Upgrade to Pro+ | |
Sun Pharma | BSE | Healthcare | Pharmaceuticals | 1.67 | ₹4LCr | 36.5x | 2.53 | ₹1,664 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.2% Upside | Upgrade to Pro+ | |
Emcure Pharmaceuticals | NSE | Healthcare | Pharmaceuticals | 1.67 | ₹25.12KCr | 36.9x | 1.14 | ₹1,312.40 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.6% Upside | Upgrade to Pro+ | |
Sun Pharma | NSE | Healthcare | Pharmaceuticals | 1.67 | ₹4LCr | 36.5x | 2.53 | ₹1,665.10 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ | |
Glenmark Pharma | BSE | Healthcare | Pharmaceuticals | 1.75 | ₹46.24KCr | 44.2x | 0.26 | ₹1,636.95 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.5% Upside | Upgrade to Pro+ | |
Abbott India | BSE | Healthcare | Pharmaceuticals | 1.75 | ₹67.20KCr | 47.4x | 2.63 | ₹31,529.10 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.2% Upside | Upgrade to Pro+ | |
Glenmark Pharma | NSE | Healthcare | Pharmaceuticals | 1.75 | ₹46.24KCr | 44.2x | 0.26 | ₹1,636.70 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.6% Upside | Upgrade to Pro+ | |
Abbott India | NSE | Healthcare | Pharmaceuticals | 1.75 | ₹67.20KCr | 47.4x | 2.62 | ₹31,620 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.9% Upside | Upgrade to Pro+ | |
Blue Jet Healthcare | BSE | Healthcare | Pharmaceuticals | 1.83 | ₹14.85KCr | 44.9x | 0.56 | ₹865.15 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.2% Upside | Upgrade to Pro+ | |
Blue Jet Healthcare | NSE | Healthcare | Pharmaceuticals | 1.83 | ₹14.85KCr | 44.9x | 0.56 | ₹865.30 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.3% Upside | Upgrade to Pro+ | |
Aurobindo Pharma | BSE | Healthcare | Pharmaceuticals | 1.85 | ₹63.81KCr | 18.3x | 1.72 | ₹1,096.20 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.7% Upside | Upgrade to Pro+ | |
Aurobindo Pharma | NSE | Healthcare | Pharmaceuticals | 1.85 | ₹63.81KCr | 18.3x | 1.73 | ₹1,097.20 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.6% Upside | Upgrade to Pro+ | |
Yatharth Hospital Trauma Care | BSE | Healthcare | Healthcare Providers & Services | 2 | ₹4.87KCr | 34.4x | 19.36 | ₹513.60 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.4% Upside | Upgrade to Pro+ | |
Mankind Pharma | BSE | Healthcare | Pharmaceuticals | 2 | ₹95.97KCr | 50x | 15.15 | ₹2,289.05 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Yatharth Hospital Trauma Care | NSE | Healthcare | Healthcare Providers & Services | 2 | ₹4.87KCr | 34.4x | 19.36 | ₹514.10 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.6% Upside | Upgrade to Pro+ | |
Concord Biotech | BSE | Healthcare | Pharmaceuticals | 2 | ₹20.64KCr | 52.8x | 2.7 | ₹1,840.05 | -6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.5% Downside | Upgrade to Pro+ | |
Mankind Pharma | NSE | Healthcare | Pharmaceuticals | 2 | ₹95.97KCr | 50x | 15.15 | ₹2,288.80 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.3% Upside | Upgrade to Pro+ | |
Concord Biotech | NSE | Healthcare | Pharmaceuticals | 2 | ₹20.64KCr | 52.8x | 2.7 | ₹1,837.30 | -6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.7% Downside | Upgrade to Pro+ | |
Metropolis Healthcare | NSE | Healthcare | Healthcare Providers & Services | 2.11 | ₹8.72KCr | 59x | 4.56 | ₹1,724.20 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
Metropolis Healthcare | BSE | Healthcare | Healthcare Providers & Services | 2.11 | ₹8.72KCr | 59x | 4.57 | ₹1,720.35 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Torrent Pharma | BSE | Healthcare | Pharmaceuticals | 2.11 | ₹1.08LCr | 56x | 3.65 | ₹3,168.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.6% Upside | Upgrade to Pro+ | |
Torrent Pharma | NSE | Healthcare | Pharmaceuticals | 2.11 | ₹1.08LCr | 56x | 3.64 | ₹3,167.20 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.7% Upside | Upgrade to Pro+ | |
Cipla | NSE | Healthcare | Pharmaceuticals | 2.11 | ₹1.21LCr | 23x | 0.81 | ₹1,499.70 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Cipla | BSE | Healthcare | Pharmaceuticals | 2.11 | ₹1.21LCr | 23x | 0.81 | ₹1,500.50 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Global Health | BSE | Healthcare | Healthcare Providers & Services | 2.13 | ₹31.25KCr | 66x | 96.27 | ₹1,131.95 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Global Health | NSE | Healthcare | Healthcare Providers & Services | 2.13 | ₹31.25KCr | 66x | 96.27 | ₹1,131.50 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Ajanta Pharma Ltd-BO | BSE | Healthcare | Pharmaceuticals | 2.17 | ₹32.36KCr | 35.1x | 2.55 | ₹2,585.30 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.5% Upside | Upgrade to Pro+ | |
Ajanta Pharma Ltd | NSE | Healthcare | Pharmaceuticals | 2.17 | ₹32.36KCr | 35.1x | 2.55 | ₹2,588.20 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.3% Upside | Upgrade to Pro+ | |
Vijaya Diagnostic Centre | BSE | Healthcare | Healthcare Providers & Services | 2.25 | ₹9.67KCr | 66.8x | 3.36 | ₹931.90 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19% Upside | Upgrade to Pro+ | |
GlaxoSmithkline Pharma | BSE | Healthcare | Pharmaceuticals | 2.25 | ₹54.36KCr | 58.8x | 1.02 | ₹3,205.20 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.5% Downside | Upgrade to Pro+ | |
Lupin | BSE | Healthcare | Pharmaceuticals | 2.25 | ₹88.99KCr | 27x | 0.38 | ₹1,946.75 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
GlaxoSmithkline Pharma | NSE | Healthcare | Pharmaceuticals | 2.25 | ₹54.36KCr | 58.8x | 1.02 | ₹3,213.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.7% Downside | Upgrade to Pro+ | |
Vijaya Diagnostic Centre | NSE | Healthcare | Healthcare Providers & Services | 2.25 | ₹9.67KCr | 66.8x | 3.36 | ₹930.25 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Lupin | NSE | Healthcare | Pharmaceuticals | 2.25 | ₹88.99KCr | 27x | 0.38 | ₹1,948 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.5% Upside | Upgrade to Pro+ | |
Max Healthcare Institute | BSE | Healthcare | Healthcare Providers & Services | 2.26 | ₹1.13LCr | 104.4x | 65.81 | ₹1,213.55 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.7% Upside | Upgrade to Pro+ | |
Max Healthcare Institute | NSE | Healthcare | Healthcare Providers & Services | 2.26 | ₹1.13LCr | 104.4x | 65.89 | ₹1,213.80 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.6% Upside | Upgrade to Pro+ | |
Ipca Laboratories | BSE | Healthcare | Pharmaceuticals | 2.3 | ₹34.76KCr | 45.7x | 1.34 | ₹1,372.65 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
Ipca Laboratories | NSE | Healthcare | Pharmaceuticals | 2.3 | ₹34.76KCr | 45.7x | 1.35 | ₹1,354.40 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.4% Upside | Upgrade to Pro+ | |
Narayana Hrudayalaya | BSE | Healthcare | Healthcare Providers & Services | 2.36 | ₹38.74KCr | 48.1x | ₹1,904.15 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.1% Downside | Upgrade to Pro+ | ||
Narayana Hrudayalaya | NSE | Healthcare | Healthcare Providers & Services | 2.36 | ₹38.74KCr | 48.1x | ₹1,903.40 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.1% Downside | Upgrade to Pro+ |